Seer to Participate in the TD Cowen 46th Annual Health Care Conference
Seer (Nasdaq: SEER) will participate in the TD Cowen 46th Annual Health Care Conference in Boston on March 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Seer (Nasdaq: SEER) will participate in the TD Cowen 46th Annual Health Care Conference in Boston on March 4, 2026. Management will take part in a fireside chat at 11:10 a.m. ET, with a live webcast and archived replay available on the company website.
Details
News Market Reaction – SEER
On Feb 19, the first trading day after this news, SEER closed 2.48% above the previous close.
Data tracked by StockTitan Argus for the Feb 19 session.
Key Figures
- Conference edition
- 46th Annual
- TD Cowen Health Care Conference
- Fireside chat date
- March 4
- Scheduled conference appearance date
- Fireside chat time ET
- 11:10 a.m. ET
- Scheduled presentation start time
- Fireside chat time PT
- 8:10 a.m. PT
- Scheduled presentation start time
Historical Context
-
Announced timing and webcast details for Q4 and full-year 2025 results.
-
Nature Genetics study validating Proteograph for large-scale proteomics and biomarker discovery.
-
HUPO 2025 presentations highlighting translational power of deep proteomics across diseases.
-
Q3 2025 results with revenue growth, 51% gross margin and reiterated 2025 guidance.
-
Planned participation in UBS and Canaccord November investor conferences with webcasts.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA.
Seer’s management is scheduled to participate in a fireside chat on Wednesday, March 4th at 11:10 a.m. Eastern Time / 8:10 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others do not. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.
Media Contact:
Patrick Schmidt
pr@seer.bio
Investor Inquiries:
investor@seer.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.